Company / Return on Assets (ROA)
Astria Therapeutics, Inc. Return on Assets (ROA) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-27.5%
FY2024
5-year range
-152.9% / -22.5%
FY2020-FY2024
Trend
+3.8%
vs FY2023
Sector context
#124 of 213
Health Care
What the data says
At -27.5%, Astria Therapeutics, Inc.'s return on assets (roa) ranks #124 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -152.9% in FY2017 to -14.4% in FY2019.
Based on SEC 10-K filings.
-27.5% in FY2024 with a 5-year CAGR of -13.1%.
Declined from -22.5% to -27.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +125.3pp
- 5-Year Change
- -13.1pp
- 10-Year Change
- -
Sector benchmark
#124 of 213 in Health CareTop 58% of 213This company -27.5% Sector average -24.1%
▼
-14.0% below sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 3.8% year-over-year.
- Currently 3.4pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -27.5% | +3.8% |
| FY2023 | -28.6% | -27.4% |
| FY2022 | -22.5% | +85.3% |
| FY2021 | -152.9% | -94.5% |
| FY2020 | -78.6% | -443.9% |
| FY2019 | -14.4% | +78.1% |
| FY2018 | -66.0% | +56.8% |
| FY2017 | -152.9% | -70.5% |
| FY2016 | -89.7% | -76.4% |
| FY2015 | -50.8% | +62.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026